Berbamine derivatives: A novel class of compounds for anti-leukemia activity

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Brian Druker, Moshe Talpaz, Debra Resta et al. · New England Journal of Medicine · 2001 · 5.2K citations · Full text

Medicine, Oncology, Pharmacology +12

Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells

Mónica L. Guzmán, Sarah J. Neering, Donna Upchurch et al. · Blood · 2001 · 757 citations

Medicine, Cell Biology, Oncology +7

Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification

Philipp le Coutre, Marileila Varella‐Garcia, Rossella Barni et al. · Blood · 2000 · 487 citations

Medicine, Molecular Biology, Pharmacology +15

Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia

Tomas Vilimas, Joaquina Mascarenhas, Teresa Palomero et al. · Nature Medicine · 2006 · 333 citations

Life Sciences, Molecular Biology, Oncology +12

Janus Kinase 2: A Critical Target in Chronic Myelogenous Leukemia

Ajoy K. Samanta, Hui Lin, Tong Sun et al. · Cancer Research · 2006 · 156 citations · Full text

Medicine, Oncology, Pharmacology +16